AU2001244292A1 - Use of substances modulating the expression or the function of a protein involved in the cell cycle for treating or preventing acute neural injuries - Google Patents
Use of substances modulating the expression or the function of a protein involved in the cell cycle for treating or preventing acute neural injuriesInfo
- Publication number
- AU2001244292A1 AU2001244292A1 AU2001244292A AU2001244292A AU2001244292A1 AU 2001244292 A1 AU2001244292 A1 AU 2001244292A1 AU 2001244292 A AU2001244292 A AU 2001244292A AU 2001244292 A AU2001244292 A AU 2001244292A AU 2001244292 A1 AU2001244292 A1 AU 2001244292A1
- Authority
- AU
- Australia
- Prior art keywords
- expression
- treating
- function
- cell cycle
- protein involved
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000001154 acute Effects 0.000 title 1
- 230000022131 cell cycle Effects 0.000 title 1
- 230000000051 modifying Effects 0.000 title 1
- 230000001537 neural Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR00/3673 | 2000-03-22 | ||
FR0003673A FR2806626B1 (en) | 2000-03-22 | 2000-03-22 | USE OF MODULATING SUBSTANCES FOR THE EXPRESSION OR FUNCTION OF A PROTEIN INVOLVED IN THE CELL CYCLE FOR THE TREATMENT OR PREVENTION OF ACUTE NEURAL INJURIES |
PCT/FR2001/000850 WO2001070231A2 (en) | 2000-03-22 | 2001-03-21 | Use of substances modulating the expression or the function of a protein involved in the cell cycle for treating or preventing acute neural injuries |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2001244292A1 true AU2001244292A1 (en) | 2001-12-13 |
AU2001244292B2 AU2001244292B2 (en) | 2005-09-22 |
Family
ID=8848391
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU4429201A Pending AU4429201A (en) | 2000-03-22 | 2001-03-21 | Use of substances modulating the expression or the function of a protein involved in the cell cycle for treating or preventing acute neural injuries |
AU2001244292A Ceased AU2001244292B2 (en) | 2000-03-22 | 2001-03-21 | Use of substances modulating the expression or the function of a protein involved in the cell cycle for treating or preventing acute neural injuries |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU4429201A Pending AU4429201A (en) | 2000-03-22 | 2001-03-21 | Use of substances modulating the expression or the function of a protein involved in the cell cycle for treating or preventing acute neural injuries |
Country Status (9)
Country | Link |
---|---|
US (1) | US20030060397A1 (en) |
EP (1) | EP1265602A2 (en) |
JP (1) | JP2003527428A (en) |
AU (2) | AU4429201A (en) |
CA (1) | CA2403714A1 (en) |
FR (1) | FR2806626B1 (en) |
IL (1) | IL151800A0 (en) |
WO (1) | WO2001070231A2 (en) |
ZA (1) | ZA200207448B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2899107B1 (en) * | 2006-03-30 | 2008-06-13 | Neurokin Entpr Unipersonnelle | USE OF (S) -ROSCOVITINE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT |
GB201217621D0 (en) * | 2012-10-02 | 2012-11-14 | Univ Leuven Kath | Anticonvulsant activity of gsk-3b inhibitors |
EP3280425B1 (en) | 2015-04-07 | 2022-06-01 | The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone | Methods for inducing cell division of postmitotic cells |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3731293A (en) * | 1992-02-24 | 1993-09-13 | Smithkline Beecham Corporation | Protein kinase c inhibitor |
US5898029A (en) * | 1994-04-12 | 1999-04-27 | The John Hopkins University | Direct influences on nerve growth of agents that interact with immunophilins in combination with neurotrophic factors |
GB9521322D0 (en) * | 1995-10-17 | 1995-12-20 | Sandoz Ltd | Organic compounds |
FR2741881B1 (en) * | 1995-12-01 | 1999-07-30 | Centre Nat Rech Scient | NOVEL PURINE DERIVATIVES HAVING IN PARTICULAR ANTI-PROLIFERATIVE PRORIETES AND THEIR BIOLOGICAL APPLICATIONS |
TW427904B (en) * | 1995-12-07 | 2001-04-01 | American Home Prod | Neuroprotective agents |
US6087366A (en) * | 1996-03-07 | 2000-07-11 | The Trustees Of Columbia University In The City Of New York | Use of flavopiridol or a pharmaceutically acceptable salt thereof for inhibiting cell damage or cell death |
EP1003519A4 (en) * | 1997-03-03 | 2003-08-20 | Univ Texas | Supression of cyclin kinase 2 activity for prevention and treatment of dna viral infections |
EP1003746A1 (en) * | 1997-08-07 | 2000-05-31 | The Regents Of The University Of California | Purine inhibitor of protein kinases, g proteins and polymerases |
US6147109A (en) * | 1997-10-14 | 2000-11-14 | The General Hospital Corporation | Upregulation of Type III endothelial cell Nitric Oxide Synthase by HMG-CoA reductase inhibitors |
EP0911634A1 (en) * | 1997-10-24 | 1999-04-28 | Het Nederlands Kanker Instituut | Pharmaceutical uses of CDK-2 regulators |
ATE355841T1 (en) * | 1997-12-13 | 2007-03-15 | Bristol Myers Squibb Co | USE OF PYRAZOLO (3,4-B)PYRIDINE AS A CYCLINE-DEPENDENT KINASE INHIBITOR |
US6479487B1 (en) * | 1998-02-26 | 2002-11-12 | Aventis Pharmaceuticals Inc. | 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines |
ES2219038T3 (en) * | 1998-02-26 | 2004-11-16 | Aventis Pharmaceuticals Inc. | 2- (TRANS- (4-AMINOCICLOHEXIL) AMINO) PURINS 6,9-DISUSTITUTED. |
FR2804959B1 (en) * | 2000-02-15 | 2006-04-28 | Centre Nat Rech Scient | USE OF PAULLON DERIVATIVES FOR THE MANUFACTURE OF MEDICAMENTS |
US20040254094A1 (en) * | 2000-10-11 | 2004-12-16 | The Trustees Of University Of Pennsylvania And Board Of Regents | Suppression of cyclin kinase activity for prevention and treatment of infections |
ATE301123T1 (en) * | 2001-06-27 | 2005-08-15 | Cyclacel Ltd | 2,6,9-SUBSTITUTED PURINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES |
-
2000
- 2000-03-22 FR FR0003673A patent/FR2806626B1/en not_active Expired - Lifetime
-
2001
- 2001-03-21 AU AU4429201A patent/AU4429201A/en active Pending
- 2001-03-21 JP JP2001568429A patent/JP2003527428A/en active Pending
- 2001-03-21 CA CA002403714A patent/CA2403714A1/en not_active Abandoned
- 2001-03-21 IL IL15180001A patent/IL151800A0/en unknown
- 2001-03-21 AU AU2001244292A patent/AU2001244292B2/en not_active Ceased
- 2001-03-21 EP EP01917205A patent/EP1265602A2/en not_active Ceased
- 2001-03-21 WO PCT/FR2001/000850 patent/WO2001070231A2/en active IP Right Grant
-
2002
- 2002-09-17 ZA ZA200207448A patent/ZA200207448B/en unknown
- 2002-09-20 US US10/251,297 patent/US20030060397A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA989249B (en) | Heteroaromatic compounds and their use in medicine. | |
AR011565A3 (en) | A MOISTURIZING, LIQUID AND AQUEOUS COMPOSITION | |
DE69838337D1 (en) | AMPHOLITIC POLYMERS FOR USE IN BODY CARE PRODUCTS | |
AU4058200A (en) | Treating body tissue by applying energy and substances | |
HK1010484A1 (en) | Pharmaceutical composition for use in treatment ofdiabetes. | |
DE69804659T2 (en) | 21-HYDRO-6,19-OXIDOPROGESTERONE (21OH-60P) AND THE USE THEREOF AS A MEDICINE FOR TREATING GLUCOCORTICO excess | |
EP1206203A4 (en) | Cosmetics container and applicator for one hand operation | |
ZA964762B (en) | Peptidyl heterocycles useful in the treatment of thrombin related disorders. | |
PL356784A1 (en) | Substances for use in treating psoriasis | |
ZA964761B (en) | Peptidyl heterocycles useful in the treatment of thrombin related disorders. | |
AU2001285942A1 (en) | Liquid oligosiloxane containing sulphur and the use thereof in rubber mixtures | |
AU2837301A (en) | Use of polymeric material in the treatment of hard surfaces | |
HUP0103117A3 (en) | Tnf-derived peptides for use in treating oedema | |
AU8803398A (en) | Photochromatic compounds, process for their preparation and their use in polymeric materials | |
AU2001244292A1 (en) | Use of substances modulating the expression or the function of a protein involved in the cell cycle for treating or preventing acute neural injuries | |
AU757752C (en) | Benzylidene pyrazolones, production and use thereof | |
DE69812256D1 (en) | 7-propyl-benzodiosepin-3-one and its use in perfumery | |
IL151800A0 (en) | Use of substances modulating the expression of the function of a protein involved in the cell cycle for treating or preventing acute neural injuries | |
EE200200124A (en) | Container closure process and associated closure means | |
ZA988619B (en) | Materials and methods for applying a treatment to animals. | |
GB2361231B (en) | Cosmetic container and cartridge for cosmetic container | |
ZA9711677B (en) | Surface material for absorbent articles, absorbent articles that include the surface material, and the use of the material in absorbent articles. | |
AU2002218346A1 (en) | Insoluble organic uv filters and cosmetic use thereof | |
PL338123A1 (en) | 6-pyrrolydin-2-ylpyridines, their production and application in therapy | |
DE59809730D1 (en) | BAG OR CONTAINER |